Clinical trial · Observational
Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer
NCT01848431CI-TRIAL-00048209withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): staff change and lack of ressources
Summary
Brief summary (as posted)
The evaluation of Perfusion of free flaps in patients with moderate anaemia and possible reduction of the transfusion threshold. * Trial with surgical intervention
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Open Fracture of Foot | — | UNRESOLVED | — |
| Tumor | Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- anaemia group
- description
- no blood transfusions will be given until hct falls under 25%
- label
- normal hct group
- description
- patients in group 2 will receive transfusions as is currently standard protocol outside the study
Primary outcomes (1)
- measure
- Number of Blood transfusions peri- and postoperative
- timeFrame
- 10 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * planned defect reconstruction with free flap and preoperative hematocrit of 28% or below Exclusion criteria: * coagulation disorder * Jehovah's witness * iodine allergy * renal or hepatic insufficiency
References
Publications (0)
Data not yet available
No reference posted for this study.